Cancer Glycobiology
Sugars could also be linked to other sorts of biological molecule to make glycoconjugates. The enzymatic process of glycosylation creates sugars/saccharides linked to themselves and to other
molecules by the glycosidic bond, thereby producing glycans. Glycoproteins, proteoglycans and glycolipids are the foremost abundant glycoconjugates found in mammalian cells. they're found predominantly on the outer
cell membrane and in secreted fluids. Glycoconjugates are shown to be important in cell-cell interactions thanks to the presence on the cell surface of varied glycan binding receptors additionally to the glycoconjugates themselves. Additionally to their function in folding and cellular attachment, the N-linked glycans of a protein can modulate the protein's function, in some cases acting as an toggle switch . MRM may be a mass spectrometry-based technique that has recently been used for site-specific glyosylation profiling. Although MRM has been used extensively in
metabolomics and
proteomics, its high sensitivity and linear response over a good dynamic range make it especially fitted to glycan
biomarker research and discovery.
Drugs already on the market, like heparin,
erythropoietin and a couple of anti-flu
drugs have proven effective and highlight the importance of glycans as a replacement class of drug. Additionally, the look for new anti-cancer
drugs is opening up new possibilities in glycobiology.[12] Anti-cancer
drugs with new and varied action mechanisms along side anti-inflammatory and anti-infection
drugs are today undergoing clinical trials. they'll alleviate or complete current therapies.
High Impact List of Articles
Relevant Topics in